Here’s a number worth sitting with: 920 billion RMB. That’s where China’s veterinary drug market is headed by 2026, up from 621 billion in 2020 and 850 billion last year. But the top-line growth hides a more interesting story underneath. The industry is being reshaped by three things that don’t always get discussed in the same breath — the pet boom, the antibiotic clampdown, and the slow consolidation of farms into industrial-scale operations. This isn’t your father’s animal health business anymore. Three Ways to Look at This Market The veterinary drug market isn’t one market. It’s several, layered on top of each other. How you see it depends on how…